Hanmi Pharmaceutical headquarters building Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop the next blockbuster weight-loss drug amid the worldwide Wegovy and Ozempic craze.Hanmi Science has
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology drug BH3120, which is being jointly developed with its Chinese subsidiary Beijing Hanmi Pharm by the Korean Ministry of Food and Drug Safety.Hanm
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., into a personalized obesity drug for domestic. This decision is based on the assessment that there is a market potential for developing a therapeut
Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean pharmaceutical company Hanmi Pharmaceutical Co., was granted Fast Track Designation from the U.S. Food and Drug Administration (FDA) for the treatme